logo
Plus   Neg
Share
Email

Pernod Ricard Q1 Organic Growth In Sales At 1.3%; Confirms FY20 Guidance

Pernod Ricard (PDRDF.PK,PDRDY.PK,PRN.L) reported sales of 2.48 billion euros for the first quarter of fiscal 2020, an organic growth of 1.3 percent over previous year. Reported growth in sales was 4.0 percent due to a favourable FX impact, mainly from US Dollar.

Looking forward, the company confirmed its fiscal 2020 guidance of organic growth in profit from recurring operations of between 5 percent and 7 percent. For fiscal 2020, the company expects a significantly positive FX impact on profit from recurring operations.

Pernod Ricard also said it intends to sign an agreement with an investment services provider to implement a first tranche of the share buy-back programme previously announced of up to 1 billion euros in total. Under the program, the company will undertake to acquire its own shares for a maximum amount of 150 million euros. The purchase will commence October 18, 2019 and end on December 18, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. (AAPL) unveiled a 16-inch MacBook Pro laptop with a larger screen and redesigned keyboard. It is the first major update since the MacBook Pro line was revamped three years ago. The company has moved from a 15-inch screen to a higher-resolution 16-inch screen. Facebook has launched its new payment platform called 'Facebook Pay' in the U.S., joining other tech giants like Google and Apple that have their own payment platforms. The new service will be available across Facebook and its associated apps - Messenger, Instagram and WhatsApp, the social media giant said in a blog post. The payment service supports most major credit and debit cards. Amneal Pharmaceuticals, LLC recalled certain lots of heartburn medication Ranitidine in the form of tablets and syrup for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine, above levels established by the U.S. Food and Drug Administration or FDA. The generic and specialty pharma company is recalling 94 lots of Ranitidine tablets and Syrup.
RELATED NEWS
Follow RTT
>